Unexpectedly, this analysis showed a strongly conserved methylation pattern in CDH1 promoter/enhancers both in the healthy controls and the HDGC patients. This evidence concerns the gene CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome.